Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
Journal
-
- The Lancet Rheumatology
-
The Lancet Rheumatology 2 (11), e653-e655, 2020-11
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360576120788440832
-
- ISSN
- 26659913
-
- Data Source
-
- Crossref